Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling

Kerboull, 2004, Long-term results of Charnley-Kerboull hip arthroplasty in patients younger than 50 years, Clin. Orthop. Relat. Res., 112, 10.1097/00003086-200401000-00018 Holt, 2007, The biology of aseptic osteolysis, Clin. Orthop. Relat. Res., 460, 240, 10.1097/BLO.0b013e31804b4147 Goodman, 2006, Effects of orthopaedic wear particles on osteoprogenitor cells, Biomaterials, 27, 6096, 10.1016/j.biomaterials.2006.08.023 Shao, 2015, Icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model, Biomaterials, 60, 92, 10.1016/j.biomaterials.2015.04.048 Stea, 2000, Cytokines and osteolysis around total hip prostheses, Cytokine, 12, 1575, 10.1006/cyto.2000.0753 Merkel, 1999, Tumor necrosis factor-alpha mediates orthopedic implant osteolysis, Am. J. Pathol., 154, 203, 10.1016/S0002-9440(10)65266-2 Tordjman, 2017, Melatonin: pharmacology functions and therapeutic benefits, Curr. Neuropharmacol., 15, 434, 10.2174/1570159X14666161228122115 Suzuki, 2008, Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases, J. Pineal Res., 44, 326, 10.1111/j.1600-079X.2007.00533.x Suzuki, 2002, Melatonin suppresses osteoclastic and osteoblastic activities in the scales of goldfish, J. Pineal Res., 33, 253, 10.1034/j.1600-079X.2002.02953.x Amstrup, 2015, Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial, J. Pineal Res., 59, 221, 10.1111/jpi.12252 Maria, 2014, Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures, J. Pineal Res., 56, 115, 10.1111/jpi.12116 El-Gammal, 2016, Clinical and radiographic evaluation of immediate loaded dental implants with local application of melatonin: a preliminary randomized controlled clinical trial, J. Oral Implantol., 42, 119, 10.1563/aaid-joi-D-14-00277 Ping, 2017, Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/beta-catenin signaling pathway, Acta Biomater., 51, 513, 10.1016/j.actbio.2017.01.034 Geng, 2010, Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist, Biomaterials, 31, 1996, 10.1016/j.biomaterials.2009.11.069 Tian, 2014, The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis, Biomaterials, 35, 8937, 10.1016/j.biomaterials.2014.06.055 Koyama, 2002, Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation, J. Bone Miner. Res., 17, 1219, 10.1359/jbmr.2002.17.7.1219 Sawyer, 2003, Quantification of tartrate resistant acid phosphatase distribution in mouse tibiae using image analysis, Biotechnol. Histochem., 78, 271, 10.1080/10520290310001646668 Hu, 2017, Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway, Acta Biomater., 48, 479, 10.1016/j.actbio.2016.11.022 Nich, 2011, Oestrogen deficiency modulates particle-induced osteolysis, Arthritis Res. Ther., 13, R100, 10.1186/ar3381 Takayanagi, 2002, RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta, Nature, 416, 744, 10.1038/416744a Teitelbaum, 2007, Osteoclasts: what do they do and how do they do it?, Am. J. Pathol., 170, 427, 10.2353/ajpath.2007.060834 Finco, 1995, Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis, Immunity, 3, 263, 10.1016/1074-7613(95)90112-4 Boyce, 2010, Functions of nuclear factor kappaB in bone, Ann. N. Y. Acad. Sci., 1192, 367, 10.1111/j.1749-6632.2009.05315.x Lee, 2003, Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts, Biochem. Biophys. Res. Commun., 305, 211, 10.1016/S0006-291X(03)00695-8 Franzoso, 1997, Requirement for NF-kappaB in osteoclast and B-cell development, Genes Dev., 11, 3482, 10.1101/gad.11.24.3482 Iotsova, 1997, Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2, Nat. Med., 3, 1285, 10.1038/nm1197-1285 Clohisy, 2004, NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis, J. Orthop. Res., 22, 13, 10.1016/S0736-0266(03)00156-6 Lin, 2016, NF-kappaB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model, Acta Biomater., 41, 273, 10.1016/j.actbio.2016.05.038 Lin, 2016, Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-kappaB DNA-binding activity, J. Pineal Res., 60, 277, 10.1111/jpi.12308 Jumnongprakhon, 2015, Melatonin protects methamphetamine-induced neuroinflammation through NF-kappaB and Nrf2 pathways in glioma cell line, Neurochem. Res., 40, 1448, 10.1007/s11064-015-1613-2 Ali, 2015, Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model, J. Pineal Res., 58, 71, 10.1111/jpi.12194 Aparicio-Soto, 2014, Melatonin modulates microsomal PGE synthase 1 and NF-E2-related factor-2-regulated antioxidant enzyme expression in LPS-induced murine peritoneal macrophages, Br. J. Pharmacol., 171, 134, 10.1111/bph.12428 Radogna, 2010, Melatonin: a pleiotropic molecule regulating inflammation, Biochem. Pharmacol., 80, 1844, 10.1016/j.bcp.2010.07.041 Taki, 2007, Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening, Bone, 40, 1276, 10.1016/j.bone.2006.12.053 Liu, 2014, Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo, Acta Biomater., 10, 4912, 10.1016/j.actbio.2014.07.025 Chahbouni, 2010, Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy, J. Pineal Res., 48, 282, 10.1111/j.1600-079X.2010.00752.x